# A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

> **NCT06033950** · PHASE3 · RECRUITING · sponsor: **Colorado Prevention Center** · enrollment: 2600 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Finerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06033950
- **Lead sponsor:** Colorado Prevention Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-20
- **Primary completion:** 2028-03
- **Final completion:** 2028-04
- **Target enrollment:** 2600 (ESTIMATED)
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06033950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06033950, "A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06033950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*